Stephanie Igwe

发表

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

Samit R. Joshi, A. S. Krishnatry, G. Ferron-Brady, 2020, Pharmacology research & perspectives.